More recently, there have been reports of increased urinary levels of KIM-1, NGAL, and NAG in patients with CKD, which could be used to predict disease progression, renal function decline, adverse renal outcomes, and mortality (21–25). Here, LCN2 is linked to chronic kidney disease.